Capsaicin protects against cisplatin ototoxicity by changing the STAT3/STAT1 ratio and activating cannabinoid (CB2) receptors in the cochlea
Three developments are converging to make 2026 a pivotal year for dermatology compounding: the FDAs peptide reclassification is restoring access to key molecules used in skin and wound healing, tightening quality standards are separating accredited pharmacies from the rest, and digital prescribing platforms are finally eliminating the operational friction that has kept many dermatologists from incorporating compounding into their standard workflow
Glycerin: Another humectant, lightweight, non-comedogenic rating of 0, and extremely well-tolerated even by sensitive, acne-prone skin
Wippermann, A., Gutowski, T., Denkena, B., & Dittrich, M
The potential effects on fetal development and the unknown presence in breast milk make these peptides inappropriate for use during pregnancy or breastfeeding